{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:29:43Z","timestamp":1791930583957,"version":"4.3.4"},"reference-count":125,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Cases of Type 2 Diabetes Mellitus (T2DM) are increasing at an alarming rate due to the rise in obesity, sedentary lifestyles, glucose-rich diets and other factors. Numerous studies have increasingly illustrated the pivotal role that human islet amyloid polypeptide (hIAPP) plays in the pathology of T2DM through damage and subsequent loss of pancreatic \u03b2-cell mass. HIAPP can misfold and form amyloid fibrils which are preceded by pre-fibrillar oligomers and monomers, all of which have been linked, to a certain extent, to \u03b2-cell cytotoxicity through a range of proposed mechanisms. This review provides an up-to-date summary of recent progress in the field, highlighting factors that contribute to hIAPP misfolding and aggregation such as hIAPP protein concentration, cell stress, molecular chaperones, the immune system response and cross-seeding with other amyloidogenic proteins. Understanding the structure of hIAPP and how these factors affect amyloid formation will help us better understand how hIAPP misfolds and aggregates and, importantly, help identify potential therapeutic targets for inhibiting amyloidosis so alternate and more effective treatments for T2DM can be developed.<\/jats:p>","DOI":"10.3390\/life12040583","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T04:21:28Z","timestamp":1650255688000},"page":"583","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"12","author":[{"given":"Adriana","family":"Sevcuka","sequence":"first","affiliation":[{"name":"Molecular Systems for Health Research Group, School of Human Sciences, London Metropolitan University, London N7 8DB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-9078","authenticated-orcid":false,"given":"Kenneth","family":"White","sequence":"additional","affiliation":[{"name":"Molecular Systems for Health Research Group, School of Human Sciences, London Metropolitan University, London N7 8DB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-8821","authenticated-orcid":false,"given":"Cassandra","family":"Terry","sequence":"additional","affiliation":[{"name":"Molecular Systems for Health Research Group, School of Human Sciences, London Metropolitan University, London N7 8DB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"25589","DOI":"10.1038\/srep25589","article-title":"Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease","volume":"6","author":"Mittal","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MED.0b013e3283488275","article-title":"Review on monogenic diabetes","volume":"18","author":"Steck","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","article-title":"Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention","volume":"13","author":"Tan","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ogc.2017.02.002","article-title":"Gestational Diabetes","volume":"44","author":"Mack","year":"2017","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nguyen, T., Ta, Q., Nguyen, T., Nguyen, T., and Van Giau, V. (2020). Type 3 diabetes and its role implications in Alzheimer\u2019s disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093165"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217S","DOI":"10.1093\/ajcn\/87.1.217S","article-title":"Glucose metabolism and hyperglycemia","volume":"87","author":"Giugliano","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref_8","unstructured":"(2022, April 06). World Health Organization. Available online: https:\/\/www.who.int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","article-title":"Epigenetics in Human Obesity and Type 2 Diabetes","volume":"29","author":"Ling","year":"2019","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes","volume":"9","author":"Xue","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00508-018-1418-9","article-title":"\u201cDiabesity\u201d\u2014Adipositas und Typ-2-Diabetes (Update 2019)","volume":"131","author":"Toplak","year":"2019","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11892-014-0508-y","article-title":"Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment","volume":"14","author":"Pulgaron","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jn\/nxx008","article-title":"Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes","volume":"148","author":"Weickert","year":"2018","journal-title":"J. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7812\/TPP\/12-099","article-title":"Understanding the Social Factors That Contribute to Diabetes: A Means to Informing Health Care and Social Policies for the Chronically Ill","volume":"17","author":"Hill","year":"2013","journal-title":"Perm. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4239\/wjd.v11.i7.293","article-title":"Gut microbiota and diabetes: From correlation to causality and mechanism","volume":"11","author":"Li","year":"2020","journal-title":"World J. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"State of the art paper Sulfonylureas and their use in clinical practice","volume":"4","author":"Sola","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/hsz-2020-0174","article-title":"Human islet amyloid polypeptide (hIAPP)\u2014A curse in type II diabetes mellitus: Insights from structure and toxicity studies","volume":"402","author":"Bishoyi","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/iub.1396","article-title":"Type-2 diabetes: Current understanding and future perspectives","volume":"67","author":"Pandey","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-8227(92)90073-Z","article-title":"Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus","volume":"15","author":"Hanabusa","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Scollo, F., and La Rosa, C. (2020). Amyloidogenic Intrinsically Disordered Proteins: New Insights into Their Self-Assembly and Their Interaction with Membranes. Life, 10.","DOI":"10.3390\/life10080144"},{"key":"ref_26","first-page":"3","article-title":"Amylin\/islet amyloid polypeptide: Biochemistry, physiology, patho-physiology","volume":"21","author":"Castillo","year":"1995","journal-title":"Diabete Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0168-8227(89)90008-9","article-title":"Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans","volume":"7","author":"Westermark","year":"1989","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","article-title":"Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The Prohormone Convertase Enzyme 2 (PC2) Is Essential for Processing Pro-Islet Amyloid Polypeptide at the NH2-Terminal Cleavage Site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.sbi.2012.11.003","article-title":"Aggregation of islet amyloid polypeptide: From physical chemistry to cell biology","volume":"23","author":"Cao","year":"2012","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_32","first-page":"E1008","article-title":"Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats","volume":"271","author":"Mulder","year":"1996","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E684","DOI":"10.1152\/ajpendo.2000.278.4.E684","article-title":"Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes","volume":"278","author":"Mulder","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Moore, S.J., Sonar, K., Bharadwaj, P., Deplazes, E., and Mancera, R.L. (2018). Characterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies. Molecules, 23.","DOI":"10.3390\/molecules23092142"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(00)01287-4","article-title":"Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils","volume":"470","author":"Higham","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","article-title":"Fibril Structure of Human Islet Amyloid Polypeptide","volume":"287","author":"Bedrood","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1021\/ja403147m","article-title":"Dynamics of an Intrinsically Disordered Protein Reveal Metastable Conformations That Potentially Seed Aggregation","volume":"135","author":"Qiao","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1021\/acs.biochem.5b00467","article-title":"Mechanism of Nucleated Conformational Conversion of A\u03b242","volume":"54","author":"Fu","year":"2015","journal-title":"Biochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1005067","DOI":"10.1371\/journal.pcbi.1005067","article-title":"How to Distinguish Conformational Selection and Induced Fit Based on Chemical Relaxation Rates","volume":"12","author":"Paul","year":"2016","journal-title":"PLOS Comput. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","article-title":"Cryo-EM structure and inhibitor design of humanIAPP (amylin) fibrils","volume":"27","author":"Cao","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41594-020-0496-3","article-title":"Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly","volume":"27","author":"Gallardo","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","article-title":"Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-\u03b2 fibrils","volume":"27","author":"Kupreichyk","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2020.08.088","article-title":"Structural characterization and cryo-electron tomography analysis of human islet amyloid polypeptide suggest a synchronous process of the hIAPP1\u221237 amyloid fibrillation","volume":"533","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41594-021-00646-x","article-title":"Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores","volume":"28","author":"Cao","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175101","DOI":"10.1063\/1.2989981","article-title":"Probing the mechanisms of fibril formation using lattice models","volume":"129","author":"Li","year":"2008","journal-title":"J. Chem. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.bbamem.2007.07.001","article-title":"Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes","volume":"1768","author":"Brender","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1074\/jbc.M801383200","article-title":"Structure of \u03b1-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding","volume":"283","author":"Apostolidou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acs.biochem.6b01016","article-title":"Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition","volume":"56","author":"Zhang","year":"2017","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12551-017-0351-x","article-title":"Membrane-mediated amyloid deposition of human islet amyloid polypeptide","volume":"10","author":"Sasahara","year":"2018","journal-title":"Biophys. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5639875","DOI":"10.1155\/2016\/5639875","article-title":"Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus","volume":"2016","author":"Caillon","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bhowmick, D.C., Kudaibergenova, Z., Burnett, L., and Jeremic, A.M. (2022). Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas. Molecules, 27.","DOI":"10.3390\/molecules27031021"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","article-title":"Phospholipid catalysis of diabetic amyloid assembly","volume":"341","author":"Knight","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jmb.2009.08.055","article-title":"Cholesterol Regulates Assembly of Human Islet Amyloid Polypeptide on Model Membranes","volume":"393","author":"Cho","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","article-title":"Insulin-degrading enzyme: New therapeutic target for diabetes and Alzheimer\u2019s disease?","volume":"48","author":"Pivovarova","year":"2016","journal-title":"Ann. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of Amylin by Insulin-degrading Enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5777","article-title":"Insulin-degrading enzyme: An ally against metabolic and neurodegenerative diseases","volume":"255","author":"Sousa","year":"2021","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures","volume":"52","author":"Bennett","year":"2003","journal-title":"Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/en.2016-1410","article-title":"Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro","volume":"157","author":"Hogan","year":"2016","journal-title":"Endocrinology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13297","article-title":"Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones","volume":"511","author":"Maianti","year":"2014","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tem.2015.11.003","article-title":"Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus","volume":"27","author":"Tang","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1110\/ps.036509.108","article-title":"Atomic structure of the cross-\u03b2 spine of islet amyloid polypeptide (amylin)","volume":"17","author":"Wiltzius","year":"2008","journal-title":"Protein Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/JME-17-0105","article-title":"The \u03b2-cell assassin: IAPP cytotoxicity","volume":"59","author":"Raleigh","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hoffmann, K.Q., McGovern, M., Chiu, C.-C., and De Pablo, J.J. (2015). Secondary Structure of Rat and Human Amylin across Force Fields. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134091"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/bm501326y","article-title":"Orientations of Residues along the \u03b2-Arch of Self-Assembled Amylin Fibril-Like Structures Lead to Polymorphism","volume":"16","author":"Miller","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/db05-1672","article-title":"\u03b2-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes","volume":"55","author":"Matveyenko","year":"2006","journal-title":"Diabetes"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e19273","DOI":"10.7554\/eLife.19273","article-title":"Atomic structures of fibrillar segments of hIAPP suggest tightly mated \u03b2-sheets are important for cytotoxicity","volume":"6","author":"Krotee","year":"2017","journal-title":"eLife"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s00125-016-4045-x","article-title":"The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets","volume":"59","author":"Entrup","year":"2016","journal-title":"Diabetologia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/acs.biochem.8b00017","article-title":"Analysis of the Role of the Conserved Disulfide in Amyloid Formation by Human Islet Amyloid Polypeptide in Homogeneous and Heterogeneous Environments","volume":"57","author":"Ridgway","year":"2018","journal-title":"Biochemistry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1038\/s41598-019-54570-8","article-title":"Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus","volume":"9","author":"Rojas","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"118971","DOI":"10.1016\/j.bbamcr.2021.118971","article-title":"Human amylin aggregates release within exosomes as a protective mechanism in pancreatic \u03b2 cells: Pancreatic \u03b2-hippocampal cell communication","volume":"1868","author":"Burillo","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)65360-6","article-title":"Intracellular Amyloidogenesis by Human Islet Amyloid Polypeptide Induces Apoptosis in COS-1 Cells","volume":"154","author":"Hiddinga","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9155","DOI":"10.1039\/c3cc44880k","article-title":"Membrane destabilization by monomeric hIAPP observed by imaging fluorescence correlation spectroscopy","volume":"49","author":"Bag","year":"2013","journal-title":"Chem. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"21274","DOI":"10.1038\/srep21274","article-title":"Pancreatic \u03b2-Cell Membrane Fluidity and Toxicity Induced by Human Islet Amyloid Polypeptide Species","volume":"6","author":"Pilkington","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0708354105","article-title":"Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane","volume":"105","author":"Engel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3310809","article-title":"A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation","volume":"331","author":"Kudva","year":"1998","journal-title":"Biochem. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1021\/jp511758w","article-title":"Probing the Sources of the Apparent Irreproducibility of Amyloid Formation: Drastic Changes in Kinetics and a Switch in Mechanism Due to Micellelike Oligomer Formation at Critical Concentrations of IAPP","volume":"119","author":"Brender","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diab.40.8.998","article-title":"Lack of Effect of Islet Amyloid Polypeptide in Causing Insulin Resistance in Conscious Dogs During Euglycemic Clamp Studies","volume":"40","author":"Upadhyay","year":"1991","journal-title":"Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev-biochem-072909-095555","article-title":"Endoplasmic Reticulum Stress and Type 2 Diabetes","volume":"81","author":"Back","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","article-title":"The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus","volume":"29","author":"Eizirik","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"44041","DOI":"10.1038\/srep44041","article-title":"The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes","volume":"7","author":"Camargo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6501046","DOI":"10.1155\/2017\/6501046","article-title":"Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans","volume":"2017","author":"Marrocco","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.06.006","article-title":"The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease","volume":"202","author":"Stephens","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.2337\/diabetes.53.2007.S119","article-title":"\u03b2-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes","volume":"53","author":"Robertson","year":"2004","journal-title":"Diabetes"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mor\u00f3n, E.B., Abad-Jim\u00e9nez, Z., De Mara\u00f1\u00f3n, A.M., Iannantuoni, F., L\u00f3pez, E., L\u00f3pez-Dom\u00e8nech, S., Salom, C., Jover, A., Mora, V., and Roldan, I. (2019). Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091385"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3765173","DOI":"10.1155\/2016\/3765173","article-title":"High Glucose-Induced Oxidative Stress Mediates Apoptosis and Extracellular Matrix Metabolic Imbalances Possibly via p38 MAPK Activation in Rat Nucleus Pulposus Cells","volume":"2016","author":"Cheng","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","article-title":"Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis","volume":"52","author":"Zraika","year":"2009","journal-title":"Diabetologia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Liguori, L., Monticelli, M., Allocca, M., Mele, B.H., Lukas, J., Cubellis, M.V., and Andreotti, G. (2020). Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020489"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/gerona\/61.5.435","article-title":"The Effect of Aging on the Chaperone Concentrations in the Hepatic, Endoplasmic Reticulum of Male Rats: The Possible Role of Protein Misfolding Due to the Loss of Chaperones in the Decline in Physiological Function Seen With Age","volume":"61","author":"Erickson","year":"2006","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cadavez, L., Montane, J., Alcarraz-Viz\u00e1n, G., Visa, M., Vidal-F\u00e0brega, L., Servitja, J.-M., and Novials, A. (2014). Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101797"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-G\u00f3mez, I., Sabl\u00f3n-Carrazana, M., Bencomo-Mart\u00ednez, A., Dom\u00ednguez, G., Lara-Mart\u00ednez, R., Altamirano-Bustamante, N.F., Jim\u00e9nez-Garc\u00eda, L.F., Pasten-Hidalgo, K., Castillo-Rodr\u00edguez, R.A., and Altamirano, P. (2018). Diabetes Drug Discovery: hIAPP1\u201337 Polymorphic Amyloid Structures as Novel Therapeutic Targets. Molecules, 23.","DOI":"10.3390\/molecules23030686"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12192-010-0204-z","article-title":"Increased serum HSP70 levels are associated with the duration of diabetes","volume":"15","author":"Nakhjavani","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ladjimi, M., Chaari, A., and Eliezer, D. (2016, January 22\u201323). Inhibition of Human Islet Amyloid Polypeptide Aggregation in Type 2 Diabetes by Hsp70 Molecular Chaperones. Proceedings of the Qatar Foundation Annual Research Conference Proceedings 2016, Doha, Qatar.","DOI":"10.5339\/qfarc.2016.HBPP2702"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bpj.2020.12.019","article-title":"Hsp70 Inhibits Aggregation of IAPP by Binding to the Heterogeneous Prenucleation Oligomers","volume":"120","author":"Chilukoti","year":"2021","journal-title":"Biophys. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/DMSO.S232133","article-title":"Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus","volume":"13","author":"Mulyani","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2018.00014","article-title":"Heparan Sulfate Proteoglycans as Emerging Players in Synaptic Specificity","volume":"11","author":"Condomitti","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/protein\/gzz041","article-title":"Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice","volume":"32","author":"Templin","year":"2019","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Brough","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/en.2012-2138","article-title":"Circulating Levels of IL-1B+IL-6 Cause ER Stress and Dysfunction in Islets From Prediabetic Male Mice","volume":"154","author":"Lu","year":"2013","journal-title":"Endocrinology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00125-020-05232-2","article-title":"Low concentration IL-1\u03b2 promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro","volume":"63","author":"Templin","year":"2020","journal-title":"Diabetologia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tem.2015.08.001","article-title":"The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications","volume":"26","author":"Herder","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5507\/bp.2018.015","article-title":"M1\/M2 macrophage polarization in human obese adipose tissue","volume":"162","author":"Chylikova","year":"2018","journal-title":"Biomed. Pap."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cjche.2020.09.033","article-title":"Amyloid cross-seeding between A\u03b2 and hIAPP in relation to the pathogenesis of Alzheimer and type 2 diabetes","volume":"30","author":"Zhang","year":"2021","journal-title":"Chin. J. Chem. Eng."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acschemneuro.5b00192","article-title":"Cross-Seeding Interaction between \u03b2-Amyloid and Human Islet Amyloid Polypeptide","volume":"6","author":"Hu","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acschemneuro.6b00247","article-title":"Molecular Understanding of A\u03b2-hIAPP Cross-Seeding Assemblies on Lipid Membranes","volume":"8","author":"Zhang","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"524a","DOI":"10.1016\/j.bpj.2014.11.2872","article-title":"Co-Aggregation of Alpha-Synuclein with Amylin(HIAPP) Leads to an Increased Risk in Type ii Diabetes Patients for Developing Parkinson\u2019s Disease","volume":"108","author":"Miller","year":"2015","journal-title":"Biophys. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1038\/s41598-020-77409-z","article-title":"\u03b1-Synuclein promotes IAPP fibril formation in vitro and \u03b2-cell amyloid formation in vivo in mice","volume":"10","author":"Mucibabic","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/ja1007867","article-title":"Role of Zinc in Human Islet Amyloid Polypeptide Aggregation","volume":"132","author":"Brender","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1038\/srep08240","article-title":"Inhibition of IAPP aggregation by insulin depends on the insulin oligomeric state regulated by zinc ion concentration","volume":"5","author":"Govindan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_113","first-page":"CD003054","article-title":"Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus","volume":"2017","author":"Hemmingsen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: Clinical use in type 2 diabetes","volume":"60","author":"Inzucchi","year":"2017","journal-title":"Diabetologia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"112197","DOI":"10.1016\/j.ejmech.2020.112197","article-title":"Non-polyphenolic natural inhibitors of amyloid aggregation","volume":"192","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of Human SIRT1 Activation by Resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4103\/1673-5374.239449","article-title":"SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes","volume":"13","author":"Li","year":"2018","journal-title":"Neural Regen. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1139\/cjpp-2016-0686","article-title":"Resveratrol attenuates hIAPP amyloid formation and restores the insulin secretion ability in hIAPP-INS1 cell line via enhancing autophagy","volume":"97","author":"Lv","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.crbiot.2020.10.002","article-title":"Insights from nature: A review of natural compounds that target protein misfolding in vivo","volume":"2","author":"Terry","year":"2020","journal-title":"Curr. Res. Biotechnol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2013.03.017","article-title":"Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives","volume":"707","author":"Bahramikia","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(02)00005-0","article-title":"Probucol preserves pancreatic \u03b2-cell function through reduction of oxidative stress in type 2 diabetes","volume":"57","author":"Gorogawa","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MJT.0b013e3181ec9eb2","article-title":"Recent and Emerging Therapeutic Medications in Type 2 Diabetes Mellitus","volume":"20","author":"Lo","year":"2013","journal-title":"Am. J. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"14031","DOI":"10.1038\/s41598-017-14311-1","article-title":"Active Immunization Against hIAPP Oligomers Ameliorates the Diabetes- Associated Phenotype in a Transgenic Mice Model","volume":"7","author":"Bram","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molmed.2017.06.003","article-title":"Amylin Receptor: A Potential Therapeutic Target for Alzheimer\u2019s Disease","volume":"23","author":"Fu","year":"2017","journal-title":"Trends Mol. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/4\/583\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:53:48Z","timestamp":1760136828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/4\/583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":125,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["life12040583"],"URL":"https:\/\/doi.org\/10.3390\/life12040583","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}